Next Generation Sequencing Market Size 2025 To 2033
- The global next-generation sequencing market size reached USD 23.3 Billion in 2024.
- The next generation sequencing market size is expected to reach USD 85.4 Billion by 2033, exhibiting a growth rate (CAGR) of 15.5% during 2025-2033.
- North America leads the market, accounting for the largest next-generation sequencing market share.
- On the basis of the sequencing type, the market is segmented into whole genome sequencing, targeted resequencing, whole exome sequencing, RNA sequencing, chip sequencing, de novo sequencing, methyl sequencing, and others.
- Based on the product type, the market is classified into instruments, reagents and consumables, software, and services.
- On the basis of the technology, the market is bifurcated into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and others.
- Based on the application, the market is segregated into biomarker and cancer, drug discovery and personalized medicine, genetic screening, diagnostics, agriculture and animal research, and others.
- On the basis of the end-user, the market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and others.
- The increasing investment in genomics research by both public and private sectors as funding enables the development of new technologies and supports large-scale genomic studies, contributing to the market expansion.
- The growing prevalence of infectious diseases and the need for rapid pathogen identification, as they allow for quick and accurate sequencing of pathogens to inform public health responses and treatment strategies, are aiding the market growth.
Request to Get the Sample Report:
https://www.imarcgroup.com/next-generation-sequencing-market/requestsample
Industry Trends and Drivers:
- Growing Demand for Personalized Medicine:
The growing focus on personalized medicine is one of the primary drivers of the next-generation sequencing (NGS) market. Personalized medicine, particularly in oncology, relies heavily on genomic data to tailor treatments to individual patients. NGS enables the identification of genetic mutations, alterations, or biomarkers that are specific to a patient’s tumor, allowing for more precise and effective treatment strategies. This approach is proving to be particularly beneficial in cancer treatment, where therapies can be matched to the genetic profile of an individual’s cancer. The expanding use of companion diagnostics, which guides therapy selection based on genomic data, is also driving the demand for NGS technologies.
Additionally, NGS is being increasingly utilized in other areas such as rare genetic diseases, pharmacogenomics, and infectious disease treatment, all contributing to the market’s growth.
- Increasing Research in Genomics:
The surge in genomic research is another significant factor propelling the NGS market forward. Government initiatives, academic institutions, and private companies are investing heavily in large-scale genomics projects, particularly in areas like cancer genomics, population genetics, and rare disease research. This research is opening new avenues for understanding complex genetic conditions, as well as identifying novel therapeutic targets.
Additionally, NGS is being used to study the genetic diversity within populations, leading to new discoveries in evolutionary biology, human migration, and ancestry. Governments across the world are supporting genomic research by providing funding and infrastructure, further driving the demand for NGS technologies.
- Technological Advancements:
The rapid technological advancements in Next Generation Sequencing (NGS) are significantly driving market growth. These innovations are improving the speed, accuracy, and affordability of sequencing processes, making it more accessible across various sectors. Sequencing platforms are now capable of handling vast amounts of genetic data in a shorter time, with improved read lengths and reduced error rates. For instance, the development of high-throughput sequencing has revolutionized genomic research, enabling scientists to sequence entire genomes or targeted regions more efficiently.
Moreover, advancements in bioinformatics tools are enhancing data analysis, interpretation, and storage, making the process more streamlined for researchers and clinicians.
Next Generation Sequencing Market Report Segmentation:
Breakup By Sequencing Type:
- Whole Genome Sequencing
- Targeted Resequencing
- Whole Exome Sequencing
- RNA Sequencing
- CHIP Sequencing
- De Novo Sequencing
- Methyl Sequencing
- Others
Based on the sequencing type, the market has been divided into whole genome sequencing, targeted resequencing, whole exome sequencing, RNA sequencing, CHIP sequencing, De Novo sequencing, methyl sequencing, and others.
Breakup By Product Type:
- Instruments
- Reagents and Consumables
- Software and Services
On the basis of product type, the market has been classified into instruments, reagents and consumables, and software and services.
Breakup By Technology:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Others
Based on the technology, the market has been categorized into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and others.
Breakup By Application:
- Biomarker and Cancer
- Drug Discovery and Personalized Medicine
- Genetic Screening
- Diagnostics
- Agriculture and Animal Research
- Others
On the basis of application, the market has been divided into biomarker and cancer, drug discovery and personalized medicine, genetic screening, diagnostics, agriculture and animal research, and others.
Breakup By End-User:
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Based on the end-user, the market has been categorized into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and others.
Breakup By Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Region-wise the market has been segmented into North America (United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
Top Next Generation Sequencing Market Leaders:
The next generation sequencing market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.
Some of the key players in the market are:
- Agilent Technologies
- Becton Dickinson and Company
- 10x Genomics, BGI Group
- Eurofins Scientific
- Hoffmann-La Roche AG
- Illumina Inc.
- Genewiz
- Macrogen
- Oxford Nanopore Technologies
- Pacific Biosciences
- PerkinElmer
- Thermo Fisher Scientific
- Qiagen N.V.
- GenapSys Inc.
Ask Analyst for Customized Report:
https://www.imarcgroup.com/request?type=report&id=2039&flag=C
Key Highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: imarcgroup.com
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
